Montse Gómez - Concepedia

Author

Montse Gómez

Hospital Clínico Universitario de Valencia

Also Known As

Alberto Alvarez-Larrán, Alberto Álvarez-Larrán, Francisco Cervantes, M. Labiós Gómez, Montse Gomez, Montse Gómez

Publications

974

Citations

H-Index

Concepts

All Affiliations

Hospital Clínico Universitario de Valencia Hospital Del Mar Hospital Clínic de Barcelona Vall d'Hebron Hospital Universitari Hospital General Universitario Morales Meseguer

About

Montse Gómez is an author at Hospital Clínico Universitario de Valencia specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	343
2	Immunology	2	2	68
3	Health Sciences	1	1	20
4	Public Health	1	1	48
5	Epidemiology	1	1	48

Montse Gómez

Publications

816

Citations

H-Index

Page 1

	Year	Citations
Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera Alberto Álvarez‐Larrán, Arturo Pereira, Francisco Cervantes, Blood	2011	221
Clinical evaluation of the European LeukaemiaNet criteria for clinicohaematological response and resistance/intolerance to hydroxycarbamide in essential thrombocythaemia Juan Carlos Hernández‐Boluda, Alberto Álvarez‐Larrán, Montse Gómez, British Journal of Haematology	2010	89
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study Tiziano Barbui, Arianna Ghirardi, Arianna Masciulli, Leukemia Hematological MalignancyMedicinePathologyNested Case-control StudySecond Cancer	2019	87
Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea Alberto Álvarez‐Larrán, Luz Martínez‐Avilés, Juan Carlos Hernández‐Boluda, Annals of Hematology ThrombosisPolycythemia VeraEssential Thrombocythemia RefractoryHematologyPharmacology	2014	76
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea Alberto Álvarez‐Larrán, Manuel Pérez‐Encinas, Francisca Ferrer‐Marín, Haematologica ThrombopoiesisThrombosisPolycythemia VeraUrologyVenous Thrombosis	2016	72
<i>JAK2</i>V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events Alberto Álvarez‐Larrán, Beatríz Bellosillo, Arturo Pereira, American Journal of Hematology Essential ThrombocythemiaMyelofibrotic TransformationImmunologyPathologyMyeloid Neoplasia	2014	48
Second cancers in MPN: Survival analysis from an international study Monia Marchetti, Arianna Ghirardi, Arianna Masciulli, American Journal of Hematology Hematological MalignancyMedicineEpidemiology Of CancerPathologySc Relapse	2019	40
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms Valerio De Stefano, Alessandra Carobbio, Vincenzo Di Lazzaro, Blood Cancer Journal	2018	37
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study Valerio De Stefano, Arianna Ghirardi, Arianna Masciulli, Blood	2019	32
Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea Alberto Álvarez‐Larrán, Marta Garrote, Francisca Ferrer‐Marín, Cancer	2022	29

Page 1